PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

PROCEPT BioRobotics (NASDAQ:PRCT) recently exceeded revenue expectations, with a loss smaller than anticipated. Analysts predict a 23% revenue increase in 2024, with a slight improvement in loss per share.